BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4002786)

  • 1. Muzolimine in chronic renal failure: a study in 16 patients.
    Stratta P; Dogliani M; Squiccimarro G; Colla L; Vercellone A
    Z Kardiol; 1985; 74 Suppl 2():125-8. PubMed ID: 4002786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term, high-dose muzolimine treatment in patients with chronic renal failure and acute fluid retention.
    Orsoni G; Di Felice A; Hadjigavriel M; Biavati M; Bonomini V
    Z Kardiol; 1985; 74 Suppl 2():121-4. PubMed ID: 4002785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
    Morachiello P; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Bazzato G
    Z Kardiol; 1985; 74 Suppl 2():115-20. PubMed ID: 4002784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muzolimine in advanced chronic renal failure.
    Mastrangelo F; Rizzelli S; Corlianò C; Alfonso L; De Blasi V; Aprile M; Montinaro AM; Napoli M
    Z Kardiol; 1985; 74 Suppl 2():109-14. PubMed ID: 4002783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of muzolimine and furosemide in heart failure.
    Salerno M; Di Salvo M; Furnari R; Vaccaro F; Licciardi S; Finocchiaro S
    Z Kardiol; 1985; 74 Suppl 2():32-3. PubMed ID: 4002801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.
    Baumelou A; Singlas E; Ritter W; Merdjan H; Martre H; Brouard R; Chickh-Touami C; Patte R
    Z Kardiol; 1985; 74 Suppl 2():88-91. PubMed ID: 4002810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study of muzolimine in acute renal failure, pharmacodynamics and pharmacokinetics.
    Bouletreau P; Meunier J; Kérihuel JC; Ritter W
    Z Kardiol; 1985; 74 Suppl 2():96-9. PubMed ID: 4002812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of muzolimine in postischemic acute renal failure in rats.
    Garthoff B
    Z Kardiol; 1985; 74 Suppl 2():171-4. PubMed ID: 4002795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose finding study in chronic congestive heart failure patients. Results of a short- and long-term study.
    Esper RJ; Esper RC; Menna J; Baglivo HP; Spiritoso R; Mosca H; Madoery RJ
    Z Kardiol; 1985; 74 Suppl 2():19-23. PubMed ID: 4002798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muzolimine as monotherapy in the treatment of patients with congestive cardiac failure.
    Oversohl K; Mehrabian G; Hanisch M; Schmitz H
    Z Kardiol; 1985; 74 Suppl 2():27-31. PubMed ID: 4002800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemide.
    Bernardi M; De Palma R; Trevisani F; Santini C; Patrono D; Motta R; Servadei D; Gasbarrini G
    Hepatology; 1986; 6(3):400-5. PubMed ID: 3519416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of muzolimine and of a combination of hydrochlorothiazide/triamterene in healthy subjects and in nephrotic patients.
    Riechers G; Futerova M; Hanisch M; Ritter W; Kühn K
    Z Kardiol; 1985; 74 Suppl 2():103-8. PubMed ID: 4002782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease.
    Dal Canton A; Russo D; Gallo R; Conte G; Andreucci VE
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):595-8. PubMed ID: 6781585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of muzolimine and furosemide in patients with end-stage renal failure on chronic dialysis.
    Schmidt P; Loew D; Dycka J; Kopsa H; Balcke P; Zazgornik J; Deutsch E
    Eur J Clin Pharmacol; 1981; 20(1):23-6. PubMed ID: 7308268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption.
    Bazzato G; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Forte M; Morachiello P
    Z Kardiol; 1985; 74 Suppl 2():92-5. PubMed ID: 4002811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of muzolimine in aortic insufficiency with different levels of left ventricular function.
    Dalla Volta S; Scognamiglio R; Sorbio MD; Fasoli G; Maragno I
    Z Kardiol; 1985; 74 Suppl 2():13-8. PubMed ID: 4002787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.